http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02124899-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef3e73bf82e05dd388bd59b6da624736
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01G1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-41
filingDate 1988-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3513fa1929000e415a40fda02238d5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69a798ac8a243976c0d7539b1faaa769
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7681536f4364bcde5aee589d908dcb83
publicationDate 1990-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02124899-A
titleOfInvention Novel protein, production thereof and immunosuppressive agent containing the same protein as active ingredient
abstract NEW MATERIAL:A protein derived from Canoderma mycelium, not coagulating human erythrocyte, having immunosuppressive ability and amino acid sequence of primary structure part expressed by the formula, etc. USE:An immunosuppressive agent. PREPARATION:For instance, Canoderma mycelium (FERM-P1826) is inoculated in medium and cultured, then cultured solution is centrifuged and mycelium is collected, thus the mycelium is suspended in buffer solution and pulverized, centrifuged, then supernatant is collected and extracted solution is obtained. Next, said extracted solution is subjected to gel chromatography and fractionated, then the active fraction is subjected to ion-exchange chromatography and adsorbed, eluted with 10mM tris-hydrochloric acid buffer solution of pH8.0, pooled the active fraction, dialyzed and freeze-dried to afford the protein expressed by the formula, etc.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009094850-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1666592-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100888850-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1666592-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002028555-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007535299-A
priorityDate 1988-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452088256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93573

Total number of triples: 30.